vs
MERIT MEDICAL SYSTEMS INC(MMSI)とEPLUS INC(PLUS)の財務データ比較。上の社名をクリックして会社を切り替えられます
EPLUS INCの直近四半期売上が大きい($614.8M vs $381.9M、MERIT MEDICAL SYSTEMS INCの約1.6倍)。MERIT MEDICAL SYSTEMS INCの純利益率が高く(10.7% vs 5.7%、差は5.0%)。EPLUS INCの前年同期比売上増加率が高い(20.3% vs 7.5%)。過去8四半期でMERIT MEDICAL SYSTEMS INCの売上複合成長率が高い(6.3% vs 2.3%)
メリットメディカルシステムズ社はグローバルな医療機器メーカーで、心臓病学、放射線学、腫瘍学、内視鏡検査、救命救護の各分野で使用される介入・診断用製品を開発・製造・販売しています。世界中の病院や医療機関に低侵襲のソリューションを提供し、患者の予後改善と診療効率の向上を支援しています。
ePlus Inc.は米国発のコンサルティング型テクノロジーソリューションプロバイダーで、サイバーセキュリティ、クラウド、ネットワーク、コラボレーション、人工知能などの先進技術分野にわたり、5000社以上の顧客にソリューション、アドバイザリー、マネージドサービスを提供しています。
MMSI vs PLUS — 直接比較
損益計算書 — Q1 FY2026 vs Q3 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $381.9M | $614.8M |
| 純利益 | $41.0M | $35.1M |
| 粗利率 | 48.4% | 25.8% |
| 営業利益率 | 11.6% | 7.1% |
| 純利益率 | 10.7% | 5.7% |
| 売上前年比 | 7.5% | 20.3% |
| 純利益前年比 | 36.0% | 45.2% |
| EPS(希薄化後) | $0.68 | $1.33 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $381.9M | — | ||
| Q4 25 | $393.9M | $614.8M | ||
| Q3 25 | $384.2M | $608.8M | ||
| Q2 25 | $382.5M | $637.3M | ||
| Q1 25 | $355.4M | — | ||
| Q4 24 | $355.2M | $493.2M | ||
| Q3 24 | $339.8M | $493.4M | ||
| Q2 24 | $338.0M | $535.7M |
| Q1 26 | $41.0M | — | ||
| Q4 25 | $38.0M | $35.1M | ||
| Q3 25 | $27.8M | $34.9M | ||
| Q2 25 | $32.6M | $37.7M | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $27.9M | $24.1M | ||
| Q3 24 | $28.4M | $31.3M | ||
| Q2 24 | $35.7M | $27.3M |
| Q1 26 | 48.4% | — | ||
| Q4 25 | 49.6% | 25.8% | ||
| Q3 25 | 48.5% | 26.6% | ||
| Q2 25 | 48.2% | 23.3% | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 48.7% | 25.4% | ||
| Q3 24 | 46.4% | 25.8% | ||
| Q2 24 | 47.7% | 23.7% |
| Q1 26 | 11.6% | — | ||
| Q4 25 | 13.8% | 7.1% | ||
| Q3 25 | 11.1% | 8.0% | ||
| Q2 25 | 12.3% | 5.7% | ||
| Q1 25 | 11.5% | — | ||
| Q4 24 | 10.3% | 3.3% | ||
| Q3 24 | 11.0% | 5.5% | ||
| Q2 24 | 13.6% | 5.9% |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.6% | 5.7% | ||
| Q3 25 | 7.2% | 5.7% | ||
| Q2 25 | 8.5% | 5.9% | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 7.9% | 4.9% | ||
| Q3 24 | 8.4% | 6.3% | ||
| Q2 24 | 10.6% | 5.1% |
| Q1 26 | $0.68 | — | ||
| Q4 25 | $0.64 | $1.33 | ||
| Q3 25 | $0.46 | $1.32 | ||
| Q2 25 | $0.54 | $1.43 | ||
| Q1 25 | $0.49 | — | ||
| Q4 24 | $0.46 | $0.91 | ||
| Q3 24 | $0.48 | $1.17 | ||
| Q2 24 | $0.61 | $1.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $488.1M | $326.3M |
| 総負債低いほど良い | $735.2M | — |
| 株主資本純資産 | $1.6B | $1.1B |
| 総資産 | $2.7B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | 0.45× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $488.1M | — | ||
| Q4 25 | $446.4M | $326.3M | ||
| Q3 25 | $392.5M | $402.2M | ||
| Q2 25 | $341.8M | $480.2M | ||
| Q1 25 | $395.5M | — | ||
| Q4 24 | $376.7M | $253.1M | ||
| Q3 24 | $523.1M | $187.5M | ||
| Q2 24 | $636.7M | $349.9M |
| Q1 26 | $735.2M | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $1.0B | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | $962.3M | ||
| Q3 24 | $1.3B | $947.0M | ||
| Q2 24 | $1.3B | $921.9M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $1.8B | ||
| Q3 25 | $2.6B | $1.8B | ||
| Q2 25 | $2.6B | $1.8B | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.4B | $1.8B | ||
| Q3 24 | $2.4B | $1.7B | ||
| Q2 24 | $2.4B | $1.7B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $-87.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.7M | — |
| FCFマージンFCF / 売上 | 6.5% | — |
| 設備投資強度設備投資 / 売上 | 4.2% | — |
| キャッシュ転換率営業CF / 純利益 | — | -2.49× |
| 直近12ヶ月FCF直近4四半期 | $220.8M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $-87.4M | ||
| Q3 25 | $75.0M | $-34.8M | ||
| Q2 25 | $83.3M | $-99.0M | ||
| Q1 25 | $40.6M | — | ||
| Q4 24 | $68.7M | $65.7M | ||
| Q3 24 | $47.3M | $-21.6M | ||
| Q2 24 | $68.5M | $97.1M |
| Q1 26 | $24.7M | — | ||
| Q4 25 | $74.0M | — | ||
| Q3 25 | $52.5M | — | ||
| Q2 25 | $69.6M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $65.3M | — | ||
| Q3 24 | $38.0M | — | ||
| Q2 24 | $57.9M | — |
| Q1 26 | 6.5% | — | ||
| Q4 25 | 18.8% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 18.4% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 17.1% | — |
| Q1 26 | 4.2% | — | ||
| Q4 25 | 6.2% | — | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | -2.49× | ||
| Q3 25 | 2.70× | -1.00× | ||
| Q2 25 | 2.56× | -2.63× | ||
| Q1 25 | 1.35× | — | ||
| Q4 24 | 2.46× | 2.72× | ||
| Q3 24 | 1.66× | -0.69× | ||
| Q2 24 | 1.92× | 3.55× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MMSI
セグメントデータなし
PLUS
| All Others Customer End Market | $107.0M | 17% |
| Technology Customer End Market | $89.4M | 15% |
| Health Care Customer End Market | $81.5M | 13% |
| Financial Services Customer End Market | $66.1M | 11% |
| Professional Services Reporting Unit | $64.1M | 10% |
| Security | $61.1M | 10% |
| State And Local Government And Educational Institutions | $59.9M | 10% |
| Managed Services Reporting Unit | $48.8M | 8% |
| Other Product | $21.1M | 3% |
| Collaboration | $13.4M | 2% |